How Mandy Cohen would bring political chops to CDC; ‘naloxone summit’ omits key advocates for lower costs

CDC directors' narrow focus as of late on science, not politics, hasn't always stood the agency in good stead. Cohen could change that.

June 15, 2023 Check out STAT+

Sponsored By

Cliff Owen/AP; Photo illustration Christine Kao/STAT Mandy Cohen, seen as next CDC director, would bring political chops to an agency lacking them In recent years, CDC directors' narrow focus on science, not politics, hasn't always stood the agency in good stead. Cohen could change that. By Helen Branswell White House 'naloxone summit' omitting prominent advocates for lower costs Nonprofits say they fear companies like Narcan's manufacturer will dominate the upcoming discussion of the opioid epidemic. By Lev Facher Opinion: What happens when patients beat their doctors to their test results Any and all clinical information must be made immediately available to patients once it is finalized. Too often, that makes my patients panic. By Christopher Medrano Adrian Kraus/AP Black former NFL players more burdened by chronic pain than white counterparts, study finds The retired tight end Julius Thomas, a co-author of new research, speaks about how athletes can increase chances of a healthier future. By Isabella Cueto STAT+ | Instead of credible data, PDS Biotech delivers 'results might get better, later' promises The company's drug, called PDS0101, is designed to recruit T cells to attack tumors caused by the human papilloma virus, or HPV. By Adam Feuerstein STAT+ | USDA to push food producers to substantiate claims that animals are raised without antibiotics The USDA will push food producers to back claims that food animals are raised without antibiotics amid concerns about drug resistance. By Ed Silverman Adobe STAT+ | Opinion: How I'm helping companies think through whether they should cover GLP-1s like Ozempic for employees GLP-1s like Ozempic are providing not just moments of hope on scales in bathrooms but moments of reckoning in boardrooms. By Owen Tripp

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser